PS

Paul Song

Chief Executive Officer

NKGen Biotech, Inc.

Los Angeles, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
NKGen Biotech, Inc.
Industry
biotechnology
Employees
58.0
Seniority
C suite
Annual Revenue
77000.0

Technologies

Route 53 Outlook Amazon AWS Mobile Friendly Facebook Login (Connect) MailChimp Facebook Widget WordPress.org Google Font API Google Tag Manager Google Analytics Remote

Keywords

immunotherapy autologous cell therapy biotechnology cellular therapeutics nk cell therapy biopharmaceutical immunooncology allogeneic cell therapy oncology cell therapy alzheimers disease neurodegenerative disease parkinsons disease biotechnology: biological products (no diagnostic substances) health care natural killer cells cell-based therapies neurodegenerative diseases oncological diseases autologous nk cells allogeneic nk cells snk platform super-activated nk cells cytotoxicity immune system cancer treatment clinical trials cell expansion activity testing fda approval tumor targeting disease elimination tumor immunology immune protection personalized medicine cytokine production antibody-dependent cellular cytotoxicity recombinant proteins manufacturing processes biomedical innovation clinical research cellular therapies biochemical assays immune response pathogen recognition infectious disease tumor metastasis brain health bioengineering biopharmaceuticals stem cell therapy cryopreservation biomarkers therapeutic potential health outcomes car-nk therapy personalized healthcare pharmaceutical industry scientific publications regulatory compliance partnerships hospital & health care health wellness & fitness

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans